投资者调整了在AstraZeneca的股份,该股份错过了收入估计,但宣布了股息。 Investors adjusted holdings in AstraZeneca, which missed earnings estimates but announced a dividend.

Fox Run Management and AXQ Capital LP公司增加了在AstraZeneca的持有量,而Marietta投资伙伴有限责任公司减少了持有量。 Fox Run Management and AXQ Capital LP have increased their holdings in AstraZeneca, while Marietta Investment Partners LLC decreased its holdings. AstraZeneca是一家生物制药公司,市场上限为2 323.7亿美元,最近报告每季度每股收入为1.05美元,缺失估计数0.05美元。 AstraZeneca, a biopharmaceutical company with a market cap of $232.37 billion, recently reported quarterly earnings per share of $1.05, missing estimates by $0.05. 该公司宣布每股半年发放1.03美元的红利,收益2%。 The company has announced a semi-annual dividend of $1.03 per share, yielding 2%. 分析员本财政年度的项目收入为4.51美元。 Analysts project earnings of $4.51 for the current fiscal year.